Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

NCT07521670 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma Metastatic
Papillary Thyroid Carcinoma

Interventions

DRUG: Sacituzumab Tirumotecan

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]
[object Object]